Search

Author/Creator Clausen, W. H. O.

2. Pharmacokinetics of a novel extended half‐life glycoPEGylated factor IX, nonacog beta pegol (N9‐GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials. Issue 4 (24th February 2017)

Authors:
Tiede, A.; Abdul‐Karim, F.; Carcao, M.; Persson, P.; Clausen, W. H. O.; Kearney, S.; Matsushita, T.; Negrier, C.; Oldenburg, J.; Santagostino, E.; Young, G.
Journal:
Haemophilia
Issue:
Volume 23:Issue 4(2017)
Page Start:
547
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program. Issue 2 (19th November 2012)

Authors:
Armstrong, M. J.; Houlihan, D. D.; Rowe, I. A.; Clausen, W. H. O.; Elbrønd, B.; Gough, S. C. L.; Tomlinson, J. W.; Newsome, P. N.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 37:Issue 2(2013)
Page Start:
234
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗